Lung Cancer Detection Rates in Early Screening Initiatives within the Mississippi Delta - Scorecard - MDSpire

Lung Cancer Detection Rates in Early Screening Initiatives within the Mississippi Delta

  • By

  • Wei Liao

  • Simon Tye

  • Jordan Goss

  • Carrie Fehnel

  • Meredith Ray

  • Raymond U. Osarogiagbon

  • April 13, 2026

  • 0 min

Share

Clinical Scorecard: Lung Cancer Detection Rates in Early Screening Initiatives within the Mississippi Delta

At a Glance

CategoryDetail
ConditionLung Cancer
Key MechanismsLow-dose computed tomography (LDCT) screening reduces lung cancer mortality and improves early-stage diagnosis.
Target PopulationDiverse populations in the Mississippi Delta with high lung cancer incidence and mortality rates.
Care SettingCommunity-based health care system serving socioeconomically diverse patients.

Key Highlights

  • NLST showed a 20% reduction in lung cancer mortality with LDCT screening.
  • Increased use of curative-intent treatment linked to early-stage diagnosis.
  • Diverse patient enrollment in incidental pulmonary nodule (IPN) programs.
  • Study approved by Institutional Review Board with low risk to participants.
  • Data collected from 2015 to 2024, focusing on demographic and clinical characteristics.

Guideline-Based Recommendations

Diagnosis

  • Use of Lung-RADS scoring system for categorizing lung nodules.

Management

  • Follow Fleischner Society guidelines for triaging patients with IPNs.

Monitoring & Follow-up

  • Regular follow-up LDCT screenings based on Lung-RADS scores.

Risks

  • Consideration of race and socioeconomic factors in lung cancer risk assessment.

Patient & Prescribing Data

Patients enrolled in LCS and IPN programs at BMHCC.

Increased early-stage diagnosis leads to improved survival outcomes.

Clinical Best Practices

  • Implement guideline-concordant treatment for incidentally detected pulmonary nodules.
  • Utilize community health initiatives to reach diverse populations.

References

Original Source(s)

Related Content